NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DVA shares have increased by 16.5% and is now trading at $87.21.
View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) announced its quarterly earnings data on Thursday, July, 30th. The company reported $1.95 EPS for the quarter, topping analysts' consensus estimates of $1.30 by $0.65. The company had revenue of $2.88 billion for the quarter, compared to the consensus estimate of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%.
View Davita's earnings history.

Davita issued an update on its FY20 earnings guidance on Thursday, July, 30th. The company provided earnings per share guidance of $6.25-$6.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.11. The company issued revenue guidance of $11.5-$11.7 billion, compared to the consensus revenue estimate of $11.70 billion.

10 Wall Street analysts have issued 12 month price objectives for Davita's stock. Their forecasts range from $57.00 to $100.00. On average, they anticipate Davita's stock price to reach $71.17 in the next twelve months. This suggests that the stock has a possible downside of 18.4%.
View analysts' price targets for Davita.

News headlines about DVA stock have been trending extremely negative recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Davita earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about Davita.

Davita saw a increase in short interest in July. As of July 15th, there was short interest totaling 6,040,000 shares, an increase of 5.6% from the June 30th total of 5,720,000 shares. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is currently 5.5 days. Currently, 5.0% of the company's stock are short sold.
View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (1.38%), State of Michigan Retirement System (0.38%), Wedge Capital Management L L P NC (0.36%), Sumitomo Mitsui Trust Holdings Inc. (0.36%), PGGM Investments (0.24%) and Envestnet Asset Management Inc. (0.17%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz.
View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Sumitomo Mitsui Trust Holdings Inc., Hexavest Inc., Mackay Shields LLC, Mn Services Vermogensbeheer B.V., Raymond James & Associates, Oregon Public Employees Retirement Fund, and Janney Montgomery Scott LLC. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz.
View insider buying and selling activity for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, Robeco Institutional Asset Management B.V., UBS Group AG, Pacer Advisors Inc., PGGM Investments, Railway Pension Investments Ltd, Raymond James Financial Services Advisors Inc., and Zurcher Kantonalbank Zurich Cantonalbank.
View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $87.21.

Davita has a market capitalization of $10.62 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]